BioClinica Inc  

(Public, NASDAQ:BIOC)   Watch this stock  
Find more results for BIOC
7.28
Mar 13 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 4.60 - 7.29
Open     -
Vol / Avg. 0.00/331,356.00
Mkt cap 113.65M
P/E 42.05
Div/yield     -
EPS 0.17
Shares 15.61M
Beta 1.28
Inst. own 44%
May 8, 2013
Q1 2013 BioClinica, Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '12) 2012
Net profit margin 4.19% 3.79%
Operating margin 7.67% 6.62%
EBITD margin - 13.56%
Return on average assets 4.72% 3.89%
Return on average equity 7.53% 6.18%
Employees 522 -
Carbon Disclosure Rating - -

Address

826 Newtown-Yardley Road
NEWTOWN, PA 18940
United States - Map
+1-267-7573000 (Phone)
+1-267-7573010 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

BioClinica, Inc. (BioClinica) provides integrated clinical research technology solutions to pharmaceutical, biotechnology, and medical device companies, and other organizations, such as contract research organizations (CRO), which is engaged in global clinical studies. The Company�s products and services include medical image management, electronic image transport and archive solutions, electronic data capture, clinical data management, interactive voice and Web response, clinical trial supply forecasting tools and clinical trial management software solutions. Its services support clinical stage research and development (R&D) functions for its clients, and specifically, the collection, cleaning and reporting of data related to their clinical trials.